ID   DUS10_HUMAN             Reviewed;         482 AA.
AC   Q9Y6W6; D3DTB4; Q6GSI4; Q9H9Z5;
DT   23-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   10-MAY-2017, entry version 159.
DE   RecName: Full=Dual specificity protein phosphatase 10;
DE            EC=3.1.3.16 {ECO:0000269|PubMed:16806267, ECO:0000269|PubMed:22375048};
DE            EC=3.1.3.48 {ECO:0000269|PubMed:16806267, ECO:0000269|PubMed:22375048};
DE   AltName: Full=Mitogen-activated protein kinase phosphatase 5;
DE            Short=MAP kinase phosphatase 5;
DE            Short=MKP-5;
GN   Name=DUSP10; Synonyms=MKP5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RX   PubMed=10391943; DOI=10.1074/jbc.274.28.19949;
RA   Tanoue T., Moriguchi T., Nishida E.;
RT   "Molecular cloning and characterization of a novel dual specificity
RT   phosphatase, MKP-5.";
RL   J. Biol. Chem. 274:19949-19956(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RX   PubMed=10597297; DOI=10.1038/sj.onc.1203185;
RA   Theodosiou A., Smith A., Gillieron C., Arkinstall S., Ashworth A.;
RT   "MKP5, a new member of the MAP kinase phosphatase family, which
RT   selectively dephosphorylates stress-activated kinases.";
RL   Oncogene 18:6981-6988(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, Lung, PNS, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 320-467, CATALYTIC ACTIVITY,
RP   SUBUNIT, TISSUE SPECIFICITY, AND ACTIVE SITE.
RX   PubMed=16806267; DOI=10.1016/j.jmb.2006.05.059;
RA   Jeong D.G., Yoon T.S., Kim J.H., Shim M.Y., Jung S.K., Son J.H.,
RA   Ryu S.E., Kim S.J.;
RT   "Crystal structure of the catalytic domain of human MAP kinase
RT   phosphatase 5: structural insight into constitutively active
RT   phosphatase.";
RL   J. Mol. Biol. 360:946-955(2006).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 148-287, SUBUNIT, AND ACTIVE
RP   SITE.
RX   PubMed=17400920; DOI=10.1110/ps.062712807;
RA   Tao X., Tong L.;
RT   "Crystal structure of the MAP kinase binding domain and the catalytic
RT   domain of human MKP5.";
RL   Protein Sci. 16:880-886(2007).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.71 ANGSTROMS) OF 139-288 IN COMPLEX WITH
RP   MAPK14, FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH MAPK14, AND
RP   MUTAGENESIS OF 180-PHE-MET-181 AND 203-ARG-ARG-204.
RX   PubMed=22375048; DOI=10.1126/scisignal.2002241;
RA   Zhang Y.Y., Wu J.W., Wang Z.X.;
RT   "A distinct interaction mode revealed by the crystal structure of the
RT   kinase p38alpha with the MAPK binding domain of the phosphatase
RT   MKP5.";
RL   Sci. Signal. 4:RA88-RA88(2011).
CC   -!- FUNCTION: Protein phosphatase involved in the inactivation of MAP
CC       kinases. Has a specificity for the MAPK11/MAPK12/MAPK13/MAPK14
CC       subfamily. It preferably dephosphorylates p38.
CC       {ECO:0000269|PubMed:10391943, ECO:0000269|PubMed:10597297,
CC       ECO:0000269|PubMed:22375048}.
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate. {ECO:0000255|PROSITE-ProRule:PRU10044,
CC       ECO:0000269|PubMed:16806267, ECO:0000269|PubMed:22375048}.
CC   -!- CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O
CC       = [a protein]-serine/threonine + phosphate.
CC       {ECO:0000269|PubMed:16806267, ECO:0000269|PubMed:22375048}.
CC   -!- SUBUNIT: Monomer. Interacts with MAPK14.
CC       {ECO:0000269|PubMed:16806267, ECO:0000269|PubMed:17400920,
CC       ECO:0000269|PubMed:22375048}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9Y6W6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y6W6-2; Sequence=VSP_036549;
CC   -!- TISSUE SPECIFICITY: Detected in brain.
CC       {ECO:0000269|PubMed:16806267}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Non-receptor class dual specificity subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/DUSP10ID49913ch1q41.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB026436; BAA81668.1; -; mRNA.
DR   EMBL; AF179212; AAD51857.1; -; mRNA.
DR   EMBL; AK022513; BAB14070.1; -; mRNA.
DR   EMBL; AL590966; CAH71120.1; -; Genomic_DNA.
DR   EMBL; CH471100; EAW93283.1; -; Genomic_DNA.
DR   EMBL; CH471100; EAW93285.1; -; Genomic_DNA.
DR   EMBL; CH471100; EAW93286.1; -; Genomic_DNA.
DR   EMBL; CH471100; EAW93287.1; -; Genomic_DNA.
DR   EMBL; BC020608; AAH20608.1; -; mRNA.
DR   EMBL; BC031405; AAH31405.1; -; mRNA.
DR   EMBL; BC063826; AAH63826.1; -; mRNA.
DR   CCDS; CCDS1528.1; -. [Q9Y6W6-1]
DR   RefSeq; NP_009138.1; NM_007207.5. [Q9Y6W6-1]
DR   UniGene; Hs.497822; -.
DR   UniGene; Hs.732301; -.
DR   PDB; 1ZZW; X-ray; 1.60 A; A/B=320-467.
DR   PDB; 2OUC; X-ray; 2.20 A; A/B=148-287.
DR   PDB; 2OUD; X-ray; 2.80 A; A=315-482.
DR   PDB; 3TG1; X-ray; 2.71 A; B=139-288.
DR   PDBsum; 1ZZW; -.
DR   PDBsum; 2OUC; -.
DR   PDBsum; 2OUD; -.
DR   PDBsum; 3TG1; -.
DR   ProteinModelPortal; Q9Y6W6; -.
DR   SMR; Q9Y6W6; -.
DR   BioGrid; 116389; 15.
DR   IntAct; Q9Y6W6; 13.
DR   MINT; MINT-8208613; -.
DR   STRING; 9606.ENSP00000355866; -.
DR   BindingDB; Q9Y6W6; -.
DR   ChEMBL; CHEMBL2396511; -.
DR   DEPOD; Q9Y6W6; -.
DR   iPTMnet; Q9Y6W6; -.
DR   PhosphoSitePlus; Q9Y6W6; -.
DR   BioMuta; DUSP10; -.
DR   DMDM; 20138090; -.
DR   PaxDb; Q9Y6W6; -.
DR   PeptideAtlas; Q9Y6W6; -.
DR   PRIDE; Q9Y6W6; -.
DR   DNASU; 11221; -.
DR   Ensembl; ENST00000366899; ENSP00000355866; ENSG00000143507. [Q9Y6W6-1]
DR   GeneID; 11221; -.
DR   KEGG; hsa:11221; -.
DR   UCSC; uc001hmy.3; human. [Q9Y6W6-1]
DR   CTD; 11221; -.
DR   DisGeNET; 11221; -.
DR   GeneCards; DUSP10; -.
DR   HGNC; HGNC:3065; DUSP10.
DR   HPA; HPA016758; -.
DR   MIM; 608867; gene.
DR   neXtProt; NX_Q9Y6W6; -.
DR   OpenTargets; ENSG00000143507; -.
DR   PharmGKB; PA27520; -.
DR   eggNOG; KOG1716; Eukaryota.
DR   eggNOG; COG2453; LUCA.
DR   GeneTree; ENSGT00760000118902; -.
DR   HOGENOM; HOG000069871; -.
DR   HOVERGEN; HBG102158; -.
DR   InParanoid; Q9Y6W6; -.
DR   KO; K20216; -.
DR   OMA; KKMTKCS; -.
DR   OrthoDB; EOG091G0V6S; -.
DR   PhylomeDB; Q9Y6W6; -.
DR   TreeFam; TF105122; -.
DR   BRENDA; 3.1.3.16; 2681.
DR   BRENDA; 3.1.3.48; 2681.
DR   Reactome; R-HSA-112409; RAF-independent MAPK1/3 activation.
DR   Reactome; R-HSA-5675221; Negative regulation of MAPK pathway.
DR   SABIO-RK; Q9Y6W6; -.
DR   SignaLink; Q9Y6W6; -.
DR   SIGNOR; Q9Y6W6; -.
DR   ChiTaRS; DUSP10; human.
DR   EvolutionaryTrace; Q9Y6W6; -.
DR   GeneWiki; DUSP10; -.
DR   GenomeRNAi; 11221; -.
DR   PRO; PR:Q9Y6W6; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143507; -.
DR   CleanEx; HS_DUSP10; -.
DR   ExpressionAtlas; Q9Y6W6; baseline and differential.
DR   Genevisible; Q9Y6W6; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0033549; F:MAP kinase phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0017017; F:MAP kinase tyrosine/serine/threonine phosphatase activity; IEA:InterPro.
DR   GO; GO:0016791; F:phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0004721; F:phosphoprotein phosphatase activity; TAS:ProtInc.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0016311; P:dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0000188; P:inactivation of MAPK activity; IDA:UniProtKB.
DR   GO; GO:0007254; P:JNK cascade; TAS:ProtInc.
DR   GO; GO:0043508; P:negative regulation of JUN kinase activity; IBA:GO_Central.
DR   GO; GO:0048715; P:negative regulation of oligodendrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0044387; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; IEA:Ensembl.
DR   GO; GO:0060266; P:negative regulation of respiratory burst involved in inflammatory response; IEA:Ensembl.
DR   GO; GO:0048709; P:oligodendrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0045591; P:positive regulation of regulatory T cell differentiation; IMP:BHF-UCL.
DR   GO; GO:0006470; P:protein dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0002819; P:regulation of adaptive immune response; IEA:Ensembl.
DR   GO; GO:0090335; P:regulation of brown fat cell differentiation; IEA:Ensembl.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0006950; P:response to stress; TAS:ProtInc.
DR   CDD; cd00127; DSPc; 1.
DR   Gene3D; 3.40.250.10; -; 1.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR020417; Atypical_DUSP.
DR   InterPro; IPR000340; Dual-sp_phosphatase_cat-dom.
DR   InterPro; IPR024950; DUSP.
DR   InterPro; IPR008343; MKP.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR001763; Rhodanese-like_dom.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   InterPro; IPR020422; TYR_PHOSPHATASE_DUAL_dom.
DR   PANTHER; PTHR10159; PTHR10159; 1.
DR   Pfam; PF00782; DSPc; 1.
DR   Pfam; PF00581; Rhodanese; 1.
DR   PRINTS; PR01908; ADSPHPHTASE.
DR   PRINTS; PR01764; MAPKPHPHTASE.
DR   SMART; SM00195; DSPc; 1.
DR   SMART; SM00450; RHOD; 1.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   SUPFAM; SSF52821; SSF52821; 1.
DR   PROSITE; PS50206; RHODANESE_3; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50054; TYR_PHOSPHATASE_DUAL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Hydrolase; Nucleus; Protein phosphatase; Reference proteome.
FT   CHAIN         1    482       Dual specificity protein phosphatase 10.
FT                                /FTId=PRO_0000094813.
FT   DOMAIN      168    285       Rhodanese. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00173}.
FT   DOMAIN      384    453       Tyrosine-protein phosphatase.
FT   REGION      199    215       Interaction with MAP kinases.
FT   ACT_SITE    408    408       Phosphocysteine intermediate.
FT                                {ECO:0000305|PubMed:16806267,
FT                                ECO:0000305|PubMed:17400920}.
FT   VAR_SEQ       1    342       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_036549.
FT   MUTAGEN     180    181       FM->DD: Reduced enzyme activity with
FT                                MAPK14. {ECO:0000269|PubMed:22375048}.
FT   MUTAGEN     203    204       RR->AA: Strongly reduced affinity for
FT                                MAPK14. Almost abolishes enzyme activity
FT                                with MAPK14.
FT                                {ECO:0000269|PubMed:22375048}.
FT   HELIX       152    160       {ECO:0000244|PDB:2OUC}.
FT   STRAND      173    176       {ECO:0000244|PDB:2OUC}.
FT   HELIX       180    185       {ECO:0000244|PDB:2OUC}.
FT   STRAND      186    188       {ECO:0000244|PDB:2OUC}.
FT   HELIX       199    206       {ECO:0000244|PDB:2OUC}.
FT   HELIX       212    217       {ECO:0000244|PDB:2OUC}.
FT   HELIX       224    230       {ECO:0000244|PDB:2OUC}.
FT   STRAND      233    236       {ECO:0000244|PDB:2OUC}.
FT   HELIX       243    245       {ECO:0000244|PDB:2OUC}.
FT   STRAND      248    250       {ECO:0000244|PDB:3TG1}.
FT   HELIX       251    261       {ECO:0000244|PDB:2OUC}.
FT   STRAND      267    269       {ECO:0000244|PDB:2OUC}.
FT   HELIX       272    276       {ECO:0000244|PDB:2OUC}.
FT   TURN        277    279       {ECO:0000244|PDB:2OUC}.
FT   HELIX       281    283       {ECO:0000244|PDB:2OUC}.
FT   STRAND      284    286       {ECO:0000244|PDB:2OUC}.
FT   STRAND      323    326       {ECO:0000244|PDB:1ZZW}.
FT   STRAND      329    332       {ECO:0000244|PDB:1ZZW}.
FT   HELIX       336    338       {ECO:0000244|PDB:1ZZW}.
FT   HELIX       340    345       {ECO:0000244|PDB:1ZZW}.
FT   STRAND      348    353       {ECO:0000244|PDB:1ZZW}.
FT   STRAND      356    358       {ECO:0000244|PDB:1ZZW}.
FT   HELIX       363    365       {ECO:0000244|PDB:1ZZW}.
FT   STRAND      368    372       {ECO:0000244|PDB:1ZZW}.
FT   STRAND      378    380       {ECO:0000244|PDB:1ZZW}.
FT   HELIX       384    386       {ECO:0000244|PDB:1ZZW}.
FT   HELIX       387    399       {ECO:0000244|PDB:1ZZW}.
FT   STRAND      403    407       {ECO:0000244|PDB:1ZZW}.
FT   STRAND      409    413       {ECO:0000244|PDB:1ZZW}.
FT   HELIX       414    426       {ECO:0000244|PDB:1ZZW}.
FT   HELIX       431    441       {ECO:0000244|PDB:1ZZW}.
FT   HELIX       449    463       {ECO:0000244|PDB:1ZZW}.
FT   HELIX       478    482       {ECO:0000244|PDB:2OUD}.
SQ   SEQUENCE   482 AA;  52642 MW;  A8CB74ABF9498CD4 CRC64;
     MPPSPLDDRV VVALSRPVRP QDLNLCLDSS YLGSANPGSN SHPPVIATTV VSLKAANLTY
     MPSSSGSARS LNCGCSSASC CTVATYDKDN QAQTQAIAAG TTTTAIGTST TCPANQMVNN
     NENTGSLSPS SGVGSPVSGT PKQLASIKII YPNDLAKKMT KCSKSHLPSQ GPVIIDCRPF
     MEYNKSHIQG AVHINCADKI SRRRLQQGKI TVLDLISCRE GKDSFKRIFS KEIIVYDENT
     NEPSRVMPSQ PLHIVLESLK REGKEPLVLK GGLSSFKQNH ENLCDNSLQL QECREVGGGA
     SAASSLLPQP IPTTPDIENA ELTPILPFLF LGNEQDAQDL DTMQRLNIGY VINVTTHLPL
     YHYEKGLFNY KRLPATDSNK QNLRQYFEEA FEFIEEAHQC GKGLLIHCQA GVSRSATIVI
     AYLMKHTRMT MTDAYKFVKG KRPIISPNLN FMGQLLEFEE DLNNGVTPRI LTPKLMGVET
     VV
//
